Meinertz T
II. Medizinische Klinik, Allgemeines Krankenhaus St. Georg, Hamburg, Germany.
J Cardiovasc Pharmacol. 1992;20 Suppl 2:S23-7.
A classification system of antiarrhythmic drugs should help the clinician to select the optimal antiarrhythmic drug for a particular arrhythmia in an individual patient. This goal cannot be achieved by the Vaughan Williams classification system. Other important goals of this classification system were to provide the clinician with some information about proarrhythmic effects and about the possibility of combining particular antiarrhythmic agents. To date, a subdivision of class III antiarrhythmic agents has not been accomplished.
抗心律失常药物的分类系统应有助于临床医生为个体患者的特定心律失常选择最佳的抗心律失常药物。而这一目标无法通过 Vaughan Williams 分类系统实现。该分类系统的其他重要目标是为临床医生提供一些有关促心律失常作用以及联合使用特定抗心律失常药物可能性的信息。迄今为止，III 类抗心律失常药物的细分尚未完成。
